Preparation and characterization of L – Dopa loaded chitosan – based dry powder: Rescue / continuous supplement in Parkinson’s disease via inhalation

Journal Title: World Journal of Pharmaceutical Sciences - Year 2016, Vol 4, Issue 1

Abstract

L – Dopa (LD) oral administration for controlling Parkinson's disease (PD) motor symptoms at the later stage will become inefficient pharmacodynamically due to the motor deteriorations result from LD fluctuated pharmacokinetic parameters especially gastrointestinal absorption and short plasma half-life. The goal from this work was preparing LD loaded chitosan-based dry powder nanoparticles (LD-CSNPs) for pulmonary delivery and hence reducing the dose required and frequency of administration. By employing Box-Behnken experimental design (BBD) for optimizing the dependent variables that include; the particle size (PS) [Y1] and encapsulation efficiency (EE) [Y2] of LD NPs prepared from chitosan (CS) by ionotropic gelation method, at different combinations of independent variables that include; CS concentration [X1], chitosan/tripolyphosphate (CS/TPP) mass ratio [X2] and LD/CS mass ratio [X3]. Ultracentrifuge, dynamic light scattering and spectrophotometer were used to measure NPs EE, size and LD quantification respectively. The optimum conditions were determined by subsequent regression and multicriteria decision analyses of the output data. The independent variables had interactive effects and greatly affect both responses. The optimum conditions for NPs production are the CS concentration [X1] of 1.2-1.6 mg/ml, CS/TPP mass ratio [X2] of 6-7 and LD/CS mass ratio [X3] of 1.8-2, which yielded NPs with PS range between 243-266 nm and EE% range between 53-58%. The x-ray powder diffraction (XRPD) shows that LD low intense peak reveal it's dispersion in a homogenous pattern and hence its nature becomes amorphous within the carrier and the Fourier transform infrared (FTIR) spectra shows that no physicochemical interaction occurs between the LD and the carrier. Korsmeyer-Peppas model was the best to fit the in vitro release data, the non-Fickian (anomalous) diffusion was the mechanism of release and the Weibull 4 model was the best for dissolution data fitting where the curve of release was parabolic (b<1, case 3). This procedure has optimized the LD-CSNPs PS and EE.

Authors and Affiliations

A. A Yas

Keywords

Related Articles

Hypertension in Pregnancy- an Overview

Most common medical disorder encountered during pregnancy is hypertension .Hypertensive disorders are one of the major causes of pregnancy-related maternal deaths in the United States. We will present a wide-ranging upda...

Formulation development and in vitro evaluation of immediate release tablets of zolpidem tartrate

Zolpidem Tartarate belongs to class II drugs, that is, characterized by low solubility and high permeability therefore, the enhancement of its solubility and dissolution profile is expected to significantly improve its b...

Protective effect of Andrographis paniculata Nees and Vitamin-C in nicotine-induced oxidative stress in liver and kidney

Nicotine, a major toxic component of cigarette smoke has been identified as a major risk factor for different diseases. In the present study, we evaluated the protective effects of aqueous extract of Andrographis panicul...

Recovery and Molecular characterization of poly-β-hydoxybutyrate polymer by Bacillus cereus isolate P83

Production of polyhydroxyalkanoates by Bacillus cereus isolate P83 was carried out in a 14L laboratory fermentor using mineral salt medium containing 0.7% corn oil and 0.1 g/L ammonium chloride as carbon and nitrogen s...

Comparative study of Cross povidone and Cross Carmellose Sodium to formulate Immediate Release Tablet of Theophylline

Oral route of drug administration have wide acceptance up to 50-60% of total dosage forms. Solid dosage forms are popular because of ease of administration, accurate dosage, self-medication, pain avoidance and most impo...

Download PDF file
  • EP ID EP194199
  • DOI -
  • Views 111
  • Downloads 0

How To Cite

A. A Yas (2016). Preparation and characterization of L – Dopa loaded chitosan – based dry powder: Rescue / continuous supplement in Parkinson’s disease via inhalation. World Journal of Pharmaceutical Sciences, 4(1), 23-36. https://europub.co.uk./articles/-A-194199